Migraine
Not recruitingStudy on Atogepant for Preventing Menstrual Migraine in Women
Study on Atogepant for Preventing Menstrual Migraine in Women
Portugal- Participants:18–64 years
- Substances:Atogepant
- Sponsor:AbbVie Deutschland GmbH & Co. KG
Rare diseases
Investigational molecules
Locations
Back to Portugal248 clinical trials in Viana Do Castelo, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on Atogepant for Preventing Menstrual Migraine in Women
PortugalStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
PortugalStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
PortugalStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
PortugalStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PortugalStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
PortugalStudy of Zolbetuximab and CAPOX for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
PortugalStudy comparing semaglutide with insulin glargine in overweight adults with type 2 diabetes: effectiveness of combined treatment versus insulin alone
PortugalStudy on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease
PortugalStudy on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease
PortugalStudy Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer
PortugalStudy on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
PortugalThe busiest research cities in the country
What the registry says about research in the country
Investigating innovative treatments for various autoimmune conditions, including Primary Sjögren's Syndrome and Lupus Erythematosus. Research focuses on evaluating new therapeutic agents for managing systemic and cutaneous manifestations.
Studies aim to improve disease control and patient quality of life through targeted interventions.
Clinical research examining treatments for inflammatory bowel conditions and digestive disorders, including Crohn's Disease and Ulcerative Colitis. Studies evaluate long-term efficacy of novel therapeutic approaches.
Investigations focus on improving treatment outcomes and disease management strategies.
Comprehensive research into Non-alcoholic Steatohepatitis (NASH) and metabolic disorders, including Type 2 Diabetes. Studies evaluate innovative treatments and combination therapies.
Research aims to address both disease progression and symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.